
New Peer-Reviewed Study Reveals Severe Health and Economic Consequences of 2025 Medicaid Policy Changes
SAN FRANCISCO, CA / ACCESS Newswire / July 16, 2025 / Waymark, a public benefit company dedicated to improving access and quality of care in Medicaid, today published peer-reviewed research in JAMA Health Forum examining the projected health system and economic impacts of 2025 Medicaid policy changes. The study, conducted in collaboration with researchers at the University of North Carolina at Chapel Hill, reveals that H.R. 1, the "One Big Beautiful Bill Act" recently passed by Congress, could result in devastating consequences for vulnerable populations, rural communities, and local economies nationwide.
Numerous studies from multiple organizations, including the nonpartisan Congressional Budget Office (CBO), estimate that Medicaid changes including eligibility restrictions, work requirements, and reduced federal matching rates would result in between 7.6 million and 14.4 million Americans becoming uninsured by 2034. Unlike previous analyses focused on enrollment projections, this study quantifies how changes in federal spending and coverage could impact population-level health outcomes and create economic ripple effects for communities across the country - particularly in rural areas already struggling with healthcare access.
Key findings:
The study projects that for every 100,000 people who lose Medicaid coverage, communities can expect substantial consequences for health outcomes and economic stability:
Health and Economic Impacts (Per 100,000 People Losing Coverage):
13-14 excess deaths annually810-924 preventable hospitalizations annually~2,582 jobs lost annually~$1.2 billion in reduced economic output annually
Healthcare System Impacts (National Scale):
Rural hospitals face heightened risk of closure, with impact disproportionate to coverage losses due to the high concentration of patients on Medicaid in rural areasFederally qualified health centers (FQHCs) experience revenue reductions of 18.7-26.1% depending on coverage loss magnitude and the degree to which patients losing Medicaid would be able to gain other forms of insurance (e.g., Exchange plans)
The study analyzed both base case and higher coverage loss scenarios, with per-capita health and economic consequences remaining consistent across both scenarios. These projected ratios can be applied regardless of the final number of people affected by the policy changes, as uncertainty remains regarding the scale of coverage losses due to administrative burdens of renewal and work requirement verification processes. The study is based on a comprehensive microsimulation model incorporating empirically derived parameters from peer-reviewed literature on health outcomes, healthcare systems, and local economies.
"This analysis demonstrates that Medicaid policy changes in H.R. 1 could have far-reaching consequences extending well beyond federal budget considerations," said Dr. Sanjay Basu MD PhD, lead author of the study and Co-Founder and Head of Clinical for Waymark. "The data shows that rural and underserved communities would bear a disproportionate burden of these policy changes, with implications for people's lives and livelihoods that state and local policymakers must carefully consider."
With H.R. 1 now signed into law, these findings provide critical insights into what communities can expect as the legislation's provisions take effect. The law includes 80-hour monthly work requirements for able-bodied adults, enhanced eligibility verification every six months, and reduced federal matching rates for expansion populations - representing the most significant restructuring of Medicaid since the program's creation.
"Medicaid affects many different aspects of people's lives," said Dr. Seth A. Berkowitz MD MPH, co-author of the study and Associate Professor of Medicine at the University of North Carolina School of Medicine. "When Medicaid gets cut, there are of course health impacts to the people who lose coverage. But there are also important impacts to the broader community, and policymakers need to consider those impacts as well."
Recognizing the importance of tracking implementation impacts, the research team has made their microsimulation model open source to enable updated estimates as implementation details are finalized. This approach ensures that policymakers and stakeholders have access to the most current projections as states develop their implementation plans.
"This research demonstrates the critical importance of understanding the full consequences of proposed Medicaid changes beyond federal budget numbers," said Dr. Sadiq Y. Patel MSW PhD, an author for the study and VP of Data Science and Artificial Intelligence for Waymark. "Our model reveals that coverage losses would cascade through communities in ways that profoundly impact public health, healthcare delivery systems, and local economies. These findings should inform policymakers about the real-world trade-offs inherent in these policy decisions."
The research letter titled "Projected Health System and Economic Impacts of 2025 Medicaid Policy Proposals" was published in JAMA Health Forum. The study was conducted by Dr. Sanjay Basu (Waymark, University of California San Francisco), Dr. Sadiq Y. Patel (Waymark, University of Pennsylvania), and Dr. Seth A. Berkowitz (University of North Carolina at Chapel Hill).
About WaymarkWaymark is a public benefit company dedicated to improving access and quality of care for people receiving Medicaid. We partner with health plans and primary care providers - including health systems, federally qualified health centers (FQHCs), and independent practices - to reduce disparities and improve outcomes through technology-enabled, community-based care. Our local teams of community health workers, pharmacists, therapists and care coordinators use proprietary data science and machine learning technologies to deliver evidence-based interventions to hard-to-reach patient populations. Waymark's peer-reviewed research has been published in leading journals including the New England Journal of Medicine (NEJM) Catalyst, Nature Scientific Reports, and Journal of the American Medical Association (JAMA)-demonstrating measurable improvements in health outcomes and cost savings for Medicaid populations. For more information, visit www.waymarkcare.com.
Contact Information
Iman Rahim Communicationsiman.rahim@waymarkcare.com
SOURCE: Waymark
press release
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time Business News
3 hours ago
- Time Business News
Emotional Eating Behaviors Fuel Caloric Surges and Health Risks
New research from Trim Body MD explores how emotional triggers shape eating behaviors and disrupt weight management goals for millions of Americans. Drawing from national consumption data and health studies, the analysis reveals that emotional eating drives up to 75 percent of overall food intake, with stress and social environments acting as major contributors. The report highlights how emotionally driven eating often replaces physical hunger with psychological responses to discomfort, boredom, or fatigue. Consumers turn to calorie-dense foods for short-term relief, triggering a cycle that includes dopamine spikes followed by guilt or frustration. This recurring loop is common across events such as the Super Bowl and family gatherings, where food becomes both ritual and coping mechanism. During Super Bowl week in 2024 alone, Americans consumed more than 100 million pounds of snack foods and an average of 11,000 calories on game day—four times the recommended daily intake. These figures reflect broader cultural patterns where social settings encourage excess without mindful awareness. Stress and lack of sleep intensify emotional eating. Elevated cortisol levels linked to chronic stress have been shown to increase cravings for sugary and fatty foods. Sleep deprivation compounds the problem by affecting hunger hormones, making it difficult to recognize satiety. Alcohol consumption, particularly during high-stress periods, disrupts sleep further and worsens hormonal balance, creating a feedback loop of cravings and poor dietary choices. The study also distinguishes emotional hunger from physical hunger. Emotional cravings emerge suddenly, often tied to specific comfort foods, and lack physical signs like a growling stomach or fatigue. In contrast, physical hunger builds gradually and responds to a wider range of food options. Learning to differentiate between these two types of hunger can help individuals regulate eating habits and avoid unnecessary calorie intake. Generational patterns reveal additional complexity. The report shows that Millennials and Gen Z are more likely to identify as emotional eaters than older adults. Social pressures, food marketing exposure, and fluctuating mental health factors all play a role in shaping behavior. Among Gen Z women, nearly 68 percent self-identified as emotional eaters, a rate far higher than that of their male peers. For some individuals, emotional eating may evolve into a clinical issue. Binge Eating Disorder (BED) is the most common eating disorder in the United States, affecting more than two million people. BED includes episodes of uncontrolled overeating, often disconnected from physical hunger and followed by emotional distress. Left untreated, it can contribute to serious health complications and disrupt weight loss efforts. The study recommends several tools for addressing emotional eating. Strategies include keeping a food journal, adopting mindful eating habits, proactively managing stress through physical activity or breathing exercises, and avoiding restrictive dieting that may lead to rebound overeating. Trim Body MD also explores potential solutions at the community level. Workplace wellness programs could offer guidance on emotional eating, while schools may benefit from early education on behavioral patterns and nutritional balance. These interventions could help future generations develop healthier relationships with food. The research concludes that emotional eating is a learned behavior with clear environmental, hormonal, and psychological roots. Understanding its triggers and differentiating it from true hunger offers a pathway toward improved health outcomes and long-term weight management. TIME BUSINESS NEWS


Business Insider
4 hours ago
- Business Insider
Bernstein Calls UnitedHealth Stock (UNH) a Top Pick Ahead of Q2 Earnings
UnitedHealth Group (UNH) stock has plunged about 42% year-to-date, due to higher costs, primarily in the Medicare Advantage (MA) segment, an abrupt CEO exit, the withdrawal of the full-year guidance, and the Department of Justice's (DOJ) probe into the company's Medicare billing practices. Ahead of the upcoming Q2 earnings on July 29, Bernstein called UNH a Top Pick, noting that the pullback in the stock due to the ongoing pressures has created a 'very attractive entry point.' Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Wall Street expects UnitedHealth to report earnings per share (EPS) of $4.88 for Q2 2025, reflecting a more than 31% year-over-year decline. Bernstein Is Bullish on UNH Stock Bernstein analyst Lance Wilkes expects UNH to benefit from a 'hardening' pricing market for government Managed Care Organizations (MCOs) and utilization decelerating back to normal levels. Wilkes lowered his 2025 EPS estimate by 10% to reflect reserve strengthening, cost pressures in Individual and Medicaid businesses, and 'clean-up of OptumHealth risk contracts for less engaged physician practices.' Wilkes expects a doubling of EPS from 2025 to 2029 at a compound annual growth rate (CAGR) of 19%, driven by sector recovery and company-specific margin recovery, while accounting for slower growth rates in UHC MA (UnitedHealthcare Medicare Advantage) and OptumHealth. Further, the analyst stated that COVID-induced Medicare cycles drove margins to trough levels, and he expects normalization to begin in the third quarter in Medicaid and in the first quarter of 2026 in MA. Wilkes contends that at the current P/E (price-to-earnings) of 13.5x, UNH stock is trading at a 'very attractive entry point.' Aside from UNH, the analyst also named Elevance Health (ELV) stock as a Top Pick. However, he noted that while ELV has similar exposures as UNH due to its diversified model, the Medicaid exposure is greater, which increases policy-related uncertainty. The analyst emphasized that the relative P/Es remain 'significantly depressed,' with UNH and ELV stocks down 50% to 60% from pre-COVID levels. He believes that these low valuation levels, which are below the relative P/E levels over the past decade, present a unique opportunity to buy UNH and ELV stocks. What Is the Price Target for UNH Stock? Wall Street has a Moderate Buy consensus rating on UnitedHealth stock based on 18 Buys, seven Holds, and one Sell recommendation. The average UNH stock price target of $355.74 indicates 21.6% upside potential.


Business Insider
5 hours ago
- Business Insider
Telomir says data show Telomir-1 reversed epigenetic silencing
In a regulatory filing, Telomir Pharmaceuticals (TELO) reported new preclinical results evaluating the effects of its lead candidate, Telomir-1, in a murine xenograft model using PC3 human prostate cancer cells. The data demonstrated that Telomir-1 reversed epigenetic silencing by DNA methylation of the STAT1 gene, a tumor suppressor and immune response regulator, in a dose-dependent manner. STAT1 is frequently silenced in advanced cancers via promoter hypermethylation, disrupting immune detection and apoptotic pathways. In this study, Telomir-1 administered orally daily for 21 days resulted in full reversal of STAT1 hypermethylation in tumor tissue. No such reversal was observed in the Paclitaxel group, and only partial demethylation was observed with Rapamycin In addition to STAT1, Telomir-1 also reduced hypermethylation of TMS1, a pro-apoptotic tumor suppressor commonly silenced in prostate cancer. While PTX and Rapamycin showed comparable or greater effects on TMS1 methylation, Telomir-1 is unique in its ability to modulate both STAT1 and TMS1-two genes that together regulate immune response and apoptosis. Importantly, TMS1 also plays a central role in inflammasome activation, which not only contributes to tumor cell death but also supports the immune system's ability to detect and clear abnormal cells. When TMS1 is hypermethylated, this immune signaling pathway is disrupted-reducing caspase-1 activation and inflammatory cytokine release. This can impair immune surveillance and allow cancer cells to persist undetected. By reducing TMS1 hypermethylation, Telomir-1 may help restore immune recognition and enhance the tumor's sensitivity to both chemotherapy and immunotherapy. Telomere length analysis in PC3 tumor tissue showed no measurable elongation following Telomir-1 administration. This finding is relevant given concerns that telomere-targeting compounds may promote tumor progression through telomere extension in malignant cells. In contrast, Telomir-1 demonstrated selective activity without altering telomere length in this model. Telomir is conducting ongoing research to evaluate Telomir-1 across multiple therapeutic areas, including oncology, Wilson's disease, age-related macular degeneration, autism spectrum disorder, and dysphonia. The company is continuing preclinical development across these programs and plans to announce its initial IND indication at a future date. 'We remain encouraged by the preclinical data and continue to explore Telomir-1's potential across several disease areas. Our team is committed to advancing this program thoughtfully and strategically as we move toward clinical development,' said Erez Aminov, CEO of Telomir. Elevate Your Investing Strategy: